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Abstract: B a c k g r o u n d: Parechovirus and enterovirus belong to a family of Picornaviridae, non-
enveloped, small-sized RNA viruses, responsible for multiple human diseases. Recent introduction 
of molecular tests enabled the identifi cation of parechovirus and enterovirus infections. Our aim was 
a retrospective analysis of signs and symptoms associated with confi rmed parechovirus or enterovirus 
infections among children treated in the Department of Neonatology, St. Louis Regional Children’s 
Hospital in Kraków, Poland.
M e t h o d s: Based on laboratory records, we identifi ed all cases of parecho- or enterovirus infections 
confi rmed by identifi cation of viral RNA in nasal swab or cerebrospinal fl uid samples. Hospital records 
and laboratory tests results of selected patients were then analyzed, and selected data were summarized, 
with emphasis on clinical and laboratory fi ndings at admission.
R e s u l t s: We identifi ed 11 cases of parechovirus and three of enterovirus infections. All cases were 
neonates admitted to hospital with fever and irritability. Except for leukopenia in 50% of patients, no 
signifi cant abnormalities were noted in blood counts and serum biochemistry, including low C-reactive 
protein and procalcitonin. In nine cases, cerebrospinal fl uid was collected, the fl uid protein concentrations 
and cell counts were moderately increased. Final diagnosis was meningitis in 12 children, and other viral 
infections in two.
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C o n c l u s i o n s: Viral infection, including parecho- and enteroviruses, should be considered in the 
etiology of fever and meningitis in neonates. Th e available molecular tests allow for detection of viral 
genetic material even in a scant biological specimen collected from neonates.
Key words: human parechovirus, human enterovirus, infection, infants, neonates.
Introduction
Th e development of modern laboratory techniques, especially in molecular biology, 
has allowed for diagnosis of former unrecognized infections. Identifi cation of viral 
diseases for many years had been based on time-consuming viral culture, primarily 
on cell lines. Currently, the advancement in the diagnostics of viral infections and the 
development of new techniques based on polymerase chain reaction (PCR) allow for 
the detection of genetic material of various microorganisms in a relatively short time.
Parechovirus and enterovirus genera belong to a widely spread family of Picorna-
viridae (Greek Pico — very small) characterized by small size of 20–35 nm, positive 
sense single-stranded RNA, and lack of envelope — the feature infl uencing their rela-
tively high resistance to environmental factors and the ways of transmission. Th e vi-
ruses belonging to Picornaviridae family (including also hepatovirus, cardiovirus and 
aphthovirus genera) are responsible for multiple human diseases, although in many 
cases, the infections in humans are asymptomatic.
Enterovirus genus includes several species pathogenic to humans (enterovirus 
A–D and rhinovirus A–C). Th e viruses may cause widespread infections of digestive 
tract, respiratory infections, or conjunctivitis, but may lead to myocarditis, meningitis 
and severe multi-organ disease. Within parechovirus genus, in turn, four species 
(A– D) have been identifi ed. Gene sequencing enabled distinguishing of 19 genotypes 
of parechovirus A called human [1–3]. Viruses belonging to the Picornaviridae family 
are the most serious threat to neonates and infants [1, 4], mainly because of the 
immature immunological system of the youngest children.
Th e symptoms of viral infections remain ambiguous and non-specifi c as they 
include fever, irritability, anxiety, often a rush, diarrhea and cough [1–4]. Both 
parechoviruses and enteroviruses can cause meningitis and sepsis in neonates [1, 2]. 
Th e viruses can spread via multiple pathways including fecal-oral, air and vertical 
transmission [5]. In the course of the infections, viremia may result in secondary site 
tissue infections. Th e material collected for laboratory examinations is very diverse 
and includes not only stool and samples from respiratory tract, but also blood and 
cerebrospinal fl uid [1].
In our center, molecular tests that enable identification of parechovirus and 
enterovirus RNA, have been introduced in the year 2017. Th e aim of the study was to 
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analyze the clinical signs and symptoms as well as laboratory test results accompanying 
the confi rmed parechovirus and enterovirus infections in children hospitalized at the 
Department of Neonatology, St. Louis Regional Children’s Hospital in Kraków, Poland.
Materials and Methods
Th is was a retrospective analysis of patients’ data from single center, the St. Louis 
Regional Children’s Hospital in Kraków, Poland. Th is is a 111-bed specialist pediatric 
center, including neonatology ward. Based on the hospital laboratory records, we 
identifi ed all cases of laboratory confi rmed parechovirus or enterovirus infection 
admitted to the Department of Neonatology of the hospital. For the identifi ed 
cases, retrospective data analysis was carried out based on the patients’ hospital 
records and laboratory test results (microbiological, hematological, biochemical and 
immunochemical). A necessary permission allowing for the utilization of patients’ 
records and test results was obtained.
Th e analysis included demographic data (age, sex), date of admission, signs and 
symptoms recorded at the admission, time of hospital stay and fi nal diagnosis, labo-
ratory test results recorded on admission (peripheral blood smear, biochemical tests 
including the serum activity of transaminases: aspartate (AST) and alanine (ALT), 
serum concentrations of urea, creatinine, C-reactive protein (CRP), procalcitonin 
(PCT), glucose, and electrolytes i.e. total calcium, magnesium, sodium, potassium, 
and chloride) and microbiological tests: blood, urine and stool cultures as well as mo-
lecular identifi cation of pneumotropic and neurotropic viruses. In a part of patients, 
biochemistry and cell count of cerebrospinal fl uid were also performed.
Nasal swab samples w ere collected for identifi cation of pneumotropic viruses, and 
cerebrospinal fl uid was collected by lumbar puncture for identifi cation of neurotropic 
viruses. The viral RNA was detected by real time PCR with the use of FTlyo 
Respiratory pathogens 21 (for nasal swab samples) and FTD Neuro9 (for cerebrospinal 
fl uid samples) (both kits from Fast Track Diagnostics Ltd., Sliema, Malta). Th e FTlyo 
Respiratory test detects influenza A virus, influenza B virus, influenza A(H1N1) 
virus, human rhinovirus, human coronavirus NL63, human coronavirus 229E, 
human coronavirus OC43, human coronavirus HKU1, human parainfluenza 1, 
human parainfluenza 2, human parainfluenza 3, human parainfluenza  4, human 
metapneumoviruses A/B, human bocavirus, human respiratory syncytial viruses 
A/B, human adenovirus, enterovirus, and human parechovirus; additionally to the 
mentioned viruses, the test detects Mycoplasma pneumoniae. Th e FTD Neuro9 test 
detects human adenovirus, human cytomegalovirus, Epstein-Barr virus, enterovirus, 
human parechovirus, herpes simplex virus 1, herpes simplex virus 2, varicella zoster 
virus, human herpesvirus 6, human herpesvirus 7, and human parvovirus B19. Th e 
tests were carried out in Department of Microbiology, University Hospital, Kraków, 
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Poland. Biochemistry and cell count of cerebrospinal fl uid were performed at the 
Department of Diagnostics, University Hospital, Kraków, Poland.
The remaining laboratory tests were conducted at the Medical Diagnostic 
Laboratory with a Bacteriological Laboratory of the St. Louis Regional Children’s 
Hospital in Kraków. Th e biochemical tests were performed using automatized analyzer 
Vitros FS 5.1. (Ortho Clinical Diagnostics, Rarithan, NJ, USA), and the complete 
blood counts using hematological analyzer Sysmex XN 550 (Sysmex Corporation, 
Kobe, Japan). Th e microbiological cultures were performed using manual methods. 
Blood cultures were carried out on Bact Alert (BioMerieux, Marcy-l’Étoile, France) for 
5 days in aerobic conditions, whereas other cultures on Oxoid plates (Th ermo Fisher 
Scientifi c, Waltham, MA, USA). Bacteria were identifi ed by means of biochemical 
tests purchased from Erba Lachema s.r.o. (Brno, Cech Republic) and antimicrobial 
susceptibility of cultured microorganisms was tested with disc-diff usion method.
Distribution of quantitative variables was assessed with Shapiro-Wilk test. For 
normally distributed variables, we reported the mean, standard deviation and range, 
while in case of non-normal distribution, median, lower, upper quartile and range. 
For qualitative data, we reported the number of children in a given category and 
the percentage of the group. Statistica 12 (StatSoft , Tusla, OK, USA) was used for 
computation.
Results
In 2018, the Department of Neonatology of St. Louis Regional Children’s Hospital in 
Kraków, Poland requested the tests towards neurotropic or pneumotropic viruses in 
19 nasal swab samples and nine cerebrospinal fl uid samples of 28 patients aged 4 days 
to six weeks. Among the patients, parechovirus or enterovirus RNA was detected in 
the nasal swab or cerebrospinal fl uid samples of 14 children.
Fig. 1. Number of cases with confi rmed parechovirus and enterovirus infection recorded in subsequent 
months of the year 2018.
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All confi rmed cases concerned neonates aged 4 to 28 days, hospitalized at the 
Neonatology Department in the period between 7th June and 12th October 2018 
(Fig. 1). Th e children were born at 37 till 41 weeks of pregnancy, eight children (57%) 
were born by Cesarean section. Except for one neonate, all were born with Apgar 
score of 9 or 10. Th e one had Apgar score of 6 at fi rst due to birth asphyxia, but it 
rose to 8 and 10 points in the following examinations and no further complications 
were reported. One child had history of dyspnea and increased C-reactive protein and 
was treated with antibiotics (ampicillin, cefuroxime, azithromycin) during two weeks 
aft er birth. Except for one, the neonates were breast-fed. Demographic and clinical 
data of the patients were presented in Table 1.
Table 1. Characteristics of studied patients with confi rmed parechovirus or enterovirus infections.
Characteristic Values
Sex:
Female, n (%)
Male, n (%)
5 (35.7)
9 (64.3)
Age <1 month, n (%) 14 (100)
Age, days
Median (Q1; Q3); minimum-maximum 21 (14; 21); 4–28
Mean birth weight (SD); minimum-maximum, g 3481 (418); 2570–4200
Symptoms at admission:
Fever (>38oC), n (%)
Anxiety/irritability, n (%)
Abdominal symptoms, n (%)
Rash, n (%)
14 (100)
14 (100)
8 (15.1)
5 (35.7)
Duration of hospital stay, days
Median (Q1; Q3); minimum-maximum 9 (8; 11); 5–14
Main etiological agent of infection
Parechovirus, n (%)
Enterovirus, n (%)
11 (78.5)
3 (21.5)
Co-occuring pathogens
Escherichia coli, n (%)
Candida parapsilosis, N (%)
Adenovirus, n (%)
2 (14.2)
1 (7.14)
1 (7.14)
Infected neonates were admitted to the ward because of fever (>38°C) and 
symptoms reported by parents such as anxiety, restlessness, and irritability, observed 
in all children. Th e symptoms lasted from few hours up to 1.5 day before admission. 
Poor feeding was reported by the parents of six neonates. Abdominal discomfort or 
pain were reported in eight cases, mucus in stool in three, one child had a single 
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episode of vomiting before the admission. None of the patients presented with cough 
or dyspnea. Th e family members (parents or siblings) of seven patients presented 
various symptoms of presumed infection (fever, cough, running nose, or diarrhea) 
in the days preceding the patients’ admission. In physical examination on admission, 
five neonates had an unspecific rash: vesicles on the edges of feet in one child, 
micropapular rash on the chest or macular rash on the thorax in the remaining four 
(Table 1). Drying mouth mucosa or coated tongue were observed in 10 patients, 
in concordance with the fever. Abdominal fl atulence, or sensitivity to palpation of 
abdominal cavity were reported in eight cases. Five had mottled skin, and two had 
prolonged (4–5 s) capillary refi ll. Reddened throat was observed in one neonate, two 
neonates had reddish tympanic membrane. Four patients were described as drowsy.
In four children presenting with symptoms of meningitis, a lumbar puncture was 
successfully performed on the fi rst day of hospital stay, and viral RNA was detected in 
the cerebrospinal fl uid using real time PCR: parechovirus was found in three children 
and enterovirus in one. In further fi ve children, parechovirus RNA was isolated from 
cerebrospinal fl uid collected later in the course of the disease. During the fi rst two 
days of hospital stay, nasal swabs were collected from 10 children and examined for 
the presence of pneumotropic viruses: the RNA of parechovirus was detected in 8 
(80%) while enterovirus in 2 (20%) patients.
Additionally, cultures of blood, urine and stool were conducted aiming at detecting 
any other infections, with an emphasis on bacteria. Escherichia coli (104 CFU/mL) 
was detected in urine samples of two children. Candida parapsilosis was cultivated 
from the stool of one infant and adenovirus DNA was detected in one nasal swab in 
addition to parechovirus RNA (Table 1). Th e results of the remaining microbiological 
tests were negative.
At admission, a panel of biochemical and hematologic tests was requested. Th e 
laboratory results were presented in Table 2. The most common laboratory sign 
was leukopenia in 50% of patients. In 5 children under 14 days old, erythrocyte 
counts were slightly reduced, in accordance with low hemoglobin. Infl ammatory 
markers: C-reactive protein and procalcitonin were low. In nine neonates (64%), 
CRP was below the upper reference limit of 10 mg/L and in fi ve patients (36%), 
slightly above the limit. Procalcitonin was within the reference range (<0.1 ng/mL) 
in all the patients. Biochemical tests including the activity of aspartate and alanine 
transaminases as well as urea, creatinine, glucose, sodium, potassium, magnesium, 
total calcium and chloride concentrations were within the reference ranges established 
for the appropriate age groups (Table 2).
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Table 2. Results of hematological and biochemical laboratory tests among neonates with confi rmed 
parechovirus or enterovirus infections.
Laboratory test (unit)
Results in the studied group Age- and sex-specifi c reference intervals
Median (Q1–Q3)
or mean ± SD
Minimum-
maximum Age Female Male
Red blood cells
(x106/μL) 3.6 (3.2–4.5) 2.9–5.9
0–14 days
14–30 days
4.12–5.74
3.32–4.8
4.10–5.55
3.16–4.63
Hemoglobin (g/dL) 12.6 (10.9–15.1) 9.9–20.6 0–14 days14–30 days
13.4–20.0
10.8–14.6
13.9–19.1
10.0–15.3
Hematocrit (%) 34.8 (29.9–41.8) 27.2–58.7 0–14 days14–30 days
39.6–57.2
32.0–44.5
39.8–53.6
30.3–45.0
MCV (fL) 93.5 ± 2.93 89.2–99.2 0–14 days14–30 days
92.7–106.4
90.1–103.0
91.3–103.1
89.4–99.7
MCH (pg) 33.3 (33.1–33.7) 32.4–36.2 0–14 days14–30 days
31.1–35.9
30.4–35.3
31.3–35.6
29.9–34.1
MCHC (g/dL) 35.9 ± 0.74 34.6–37.5 0–14 days14–30 days
33.4–35.4
33.2–35.0
33.0–35.7
32.7–35.1
RDW-CV (%) 14 (14–15) 14–17 0–14 days14–30 days
14.6–17.3
14.4–16.2
14.8–17.01
14.3–16.8
White blood cells
(x103/μL) 6.0 (4.1–7.5) 3.04–14.16
0–14 days
14–30 days
8.16–14.56
8.36–14.42
Neutrophils (%) 43 ± 19.7 13.3–81 0–14 days14–30 days
15.2–66.1
10.6–57.3
20.2–46.2
14.0–54.6
Lymphocytes (%) 36.4 ± 15.1 8.2–56.6 0–14 days14–30 days
24.9–68.5
31.9–82.7
33.7–67.6
33.6–76.8
Monocytes (%) 15.2 (13.6–25.1) 8.6–28.3 0–14 days14–30 days
5.2–20.6
5.6–13.8
6.7–19.9
4.3–18.3
Eosinophils (%) 2.43 ± 1.73 0.0–5.7 0–14 days14–30 days
0.4–4.6
0.0–5.3
0.3–5.2
0.2–5.4
Basophils (%) 0.35 (0.3–0.7) 0.1–0.8 0–14 days14–30 days
0.1–0.6
0.0–0.5
0.1–0.8
0.0–0.6
Immature granulocytes 
(%) 0.5 (0.4–0.7) 0.3–1.3
all age 
groups <2
Platelets (x103/μL) 292 ± 97.9 148–475 0–14 days14–30 days
144–449
279–571
218–419
248–586
C-reactive protein 
(mg/L) 5.5 (5–11) 5–14
all age 
groups <10
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Laboratory test (unit)
Results in the studied group Age- and sex-specifi c reference intervals
Median (Q1–Q3)
or mean ± SD
Minimum-
maximum Age Female Male
Procalcitonin (ng/mL) 0.17 (0.12–0.29) 0.07–0.4 all age groups <0.5
ALT (U/L) 36.6 ± 8.9 19–52 1–7 days7–30 days
18–39
18–44
23–38
20–45
AST (U/L) 41 (37–58) 27–79 1–7 days7–30 days
24–95
24–72
30–100
20–70
Urea (mmol/L) 3.55 ± 0.97 2.2–5.6 1–7 days7–30 days
0.7–4.6
0.7–5.4
Creatinine (μmol/L) 31.7 ± 4.42 25.9–40.4 1–7 days7–30 days
53–97
27–62
Glucose (mmol/L) 4.35 (4.18–4.89) 3.8–7.9 all age groups 3.33–5.55
Potassium (mmol/L) 5.02 ± 0.42 4.2–5.7 1–7 days7–30 days
3.25–5.5
3.4–6.0
Sodium (mmol/L) 137.2 ± 3.1 130–141 all age groups 137–145
Total calcium 
(mmol/L) 2.45 ± 0.08 2.32–2.59
1–7 days
7–30 days
1.88–2.83
2.10–2.98
1.83–2.85
2.15–2.93
Magnesium (mmol/L) 2.45 ± 0.08 2.32–2.59 1–7 days7–30 days
0.48–1.05
0.65–1.0
Chloride (mmol/L) 103.5 ± 3.36 97–108 0–6 months 96–110
Abbreviations: Q1 — lower quartile; Q3 — upper quartile; SD — standard deviation; MCV — mean cell volume; 
MCH — mean cell hemoglobin mass; MCHC — mean cell hemoglobin concentration; RDW-CV — red blood cells 
distribution width — coeffi  cient of variation; ALT — alanine aminotransferase; AST — aspartate aminotransferase.
In nine children who underwent lumbar puncture, protein concentrations in the 
cerebrospinal fl uid ranged from 50 to 89 mg/dL (upper reference limit 115 mg/ dL). 
Low glucose concentrations (2.01 mmol/L) were found in three neonates: 
2.01  mmol/L, 2.12 mmol/L, 2.19 mmol/L (lower reference limit: 2.00 mmol/L) and 
increased cell counts (0.062–0.188 × 103/uL) in seven of the patients (upper reference 
limit: 0.026 × 103/μL). Th e percentage of polymorphonuclear cells in the cerebrospinal 
fl uid ranged from 8.1% to 30.3%.
In 12 patients, meningitis of viral etiology was recognized as the fi nal diagnosis: it 
was parechovirus infection in 10 neonates (83%) and enterovirus in two (17%). Th is 
group included the nine neonates with the viral RNA isolated from cerebrospinal 
Table 2. Cont.
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fl uid samples and the other three, who developed the symptoms of meningitis during 
the hospital stay but had contraindications for lumbar puncture and the viral RNA 
was detected in nasal swab samples. In the remaining two patients, the diagnosis 
“other viral infections” (one parecho- and one enterovirus) was established according 
to International Classifi cation of Diseases (ICD 9).
Discussion
Recently, human parechovirus and enterovirus infections have been the topic 
of increasing number of studies, however, in Poland the access to specialized 
virusological tests is still limited to bigger reference centers. Th e growing numbers of 
cases with high fever of unidentifi ed etiology among children is a serious diagnostic 
problem [6–8]. Implementation of molecular methods could signifi cantly contribute 
to a more specifi c diagnosis and a more eff ective treatment.
We retrospectively identifi ed and summarized all cases of confi rmed parecho- 
or enterovirus infections recorded in the neonates admitted to St. Louis Regional 
Children’s Hospital in Kraków, Poland since the introduction of diagnostic tests based 
on real time PCR method. In 2018, the largest number of cases was reported in June 
(6 cases) and July (3 cases), what confi rms the observations of increased morbidity in 
the summer season [1, 9]. According to previous studies [4, 8, 10], neonates are the 
group most vulnerable to the infections; this susceptibility has been assigned to the 
immaturity of neonatal immunological system. In our study, all children presented 
symptoms of fever and irritability at admission, similar symptoms of parecho- and 
enterovirus infections have been observed by others [1, 8, 11]. Despite increased body 
temperature, infl ammatory markers (CRP, PCT) remained unchanged in the majority 
of cases (only slight increase in serum CRP concentrations was observed in a few 
patients). Th is observation is similar to reported by Cabrerizo et al. [12]. Th is has 
also been observed by Chang et al. [1] and could be assigned to the immaturity of 
liver function, and thus limited production and secretion of acute phase proteins. 
Meningitis was diagnosed in most identifi ed cases (85%), similarly to the reports of 
Britton et al. [13] and de Jong et al. [14].
Th ere are, however, some discrepancies between the signs of infection observed 
in our patients and the ones reported previously. Th e rash occurred in less than 40% 
of neonates treated in our center, and its characteristics diff ered between these cases. 
Th us, we cannot regard the rash as a reliable symptom of parechovirus nor enterovirus 
infection. Cumming et al. [11] reported a rash in as much as 62% of children under 
three months of age, a signifi cantly higher percentage than in our group. In another 
report, Sharp et al. [6] observed rash in seven out of 19 children [15]. Another 
symptom noted in Cumming et al. [11] is diarrhea, which developed in 31% of 
patients, however, it was not observed in our patients. In our group, the peripheral 
46 Małgorzata Kielar, Aleksandra Tokarz, et al.
blood cell counts revealed normal erythrocyte counts, hemoglobin concentrations 
and hematocrit as well as thrombocyte counts. Notably, a half of our patients had 
leukopenia, unlike the reports of other authors, who observed normal leukocyte 
counts [1, 16, 17]. Yeom et al. [18] described two cases with increased activity of 
aspartate aminotransferase, which also does not agree with our observations [18]. Th e 
diverse manifestations of the disease may be the result of the infections with diff erent 
parechovirus and enterovirus genotypes.
Blood, urine and stool cultures were performed in our patients as a part of the 
diagnostic workup (search for etiological factor of high fever in neonates). All blood 
cultures remained sterile during the 5 days of incubation in aerobic environment. 
From two urine cultures, Escherichia coli was isolated in a titer of 104 CFU/mL. 
However, titers of at least 105 CFU/mL in urine collected by spontaneous urination 
in neonates or infants are considered diagnostic of urinary tract infections. Th us, 
the presence of Escherichia coli in urine samples was most likely the consequence of 
specimen contamination during collection. In turn, Candida parapsilosis cultured in 
stool samples colonizes the digestive tract of neonates.
Conclusions
In the reported parechovirus and enterovirus infections, non-specifi c symptoms 
such as fever, irritability and restlessness were observed and except for leukopenia 
no signifi cant abnormalities were noted in basic laboratory tests. Th e identifi cation of 
the etiological factor of the disease was possible due to implementation of molecular 
method, i.e. real time PCR. In the light of more widespread availability of molecular 
techniques in medical diagnostics, identifi cation of extended panel of viruses 
should be considered in children presenting with fever of unknown etiology. Th e 
sensitivity of molecular methods opens a possibility to detect scant genetic material of 
a pathogen even in a modest amount of specimen. Th is is especially valid in neonates 
and premature infants when only small volumes of biological samples (in particular 
blood and cerebrospinal fl uid) may be acquired for laboratory tests.
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